AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(6), 2001, pp. 700-704
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheir, Z
Right arrow Articles by Hammad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheir, Z
Right arrow Articles by Hammad, S.
Related Collections
Right arrow Schistosomiasis
Right arrow Travel Medicine
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 6, 700-704
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


A safe, effective, herbal antischistosomal therapy derived from myrrh

Z Sheir, AA Nasr, A Massoud, O Salama, GA Badra, H El-Shennawy, N Hassan, and SM Hammad

Schistosomiasis is a widespread helminthic disease. Treatment of schistosomiasis is based on chemotherapy with praziquantel, which is the drug of choice. Since resistance to praziquantel has been demonstrated, alternative drugs must be considered. Myrrh is an oleo-gum resin from the stem of the plant Commiphora molmol. This study was carried out on 204 patients with schistosomiasis. The drug was given at a dose of 10 mg/kg of body weight/day for three days, and induced a cure rate of 91.7%. Re-treatment of cases who did not respond with a dose of 10 mg/kg of body weight/day for six days gave a cure rate of 76.5%, increasing the overall cure rate to 98.09%. The drug was well tolerated, and side effects were mild and transient. Twenty cases provided biopsy specimens six months after treatment and none of them showed living ova.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
J. KEISER, N. A. EL ELA, E. EL KOMY, N. EL LAKKANY, T. DIAB, J. CHOLLET, J. UTZINGER, and R. BARAKAT
Triclabendazole and its two main metabolites lack activity against schistosoma mansoni in the mouse model.
Am J Trop Med Hyg, August 1, 2006; 75(2): 287 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. BARAKAT, H. ELMORSHEDY, and A. FENWICK
EFFICACY OF MYRRH IN THE TREATMENT OF HUMAN SCHISTOSOMIASIS MANSONI
Am J Trop Med Hyg, August 1, 2005; 73(2): 365 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. BOTROS, H. SAYED, H. EL-DUSOKI, H. SABRY, I. RABIE, M. EL-GHANNAM, M. HASSANEIN, Y. A. EL-WAHAB, and D. ENGELS
EFFICACY OF MIRAZID IN COMPARISON WITH PRAZIQUANTEL IN EGYPTIAN SCHISTOSOMA MANSONI-INFECTED SCHOOL CHILDREN AND HOUSEHOLDS
Am J Trop Med Hyg, February 1, 2005; 72(2): 119 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. BOTROS, S. WILLIAM, F. EBEID, D. CIOLI, N. KATZ, T. A. DAY, and J. L. BENNETT
LACK OF EVIDENCE FOR AN ANTISCHISTOSOMAL ACTIVITY OF MYRRH IN EXPERIMENTAL ANIMALS
Am J Trop Med Hyg, August 1, 2004; 71(2): 206 - 210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.